Hepatocyte-specific SLC27A4 deletion ameliorates nonalcoholic fatty liver disease in mice via suppression of phosphatidylcholine-mediated PXR activation
- 1 November 2024
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 162, 156054
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Methionine‐ and Choline‐Deficient Diet Enhances Adipose Lipolysis and Leptin Release in aP2‐Cre Fatp4‐Knockout MiceMolecular Nutrition & Food Research, 2020
- The Nuclear Orphan Receptor NR2F6 Promotes Hepatic Steatosis through Upregulation of Fatty Acid Transporter CD36Advanced Science, 2020
- Multiple Parallel Hits Hypothesis in Nonalcoholic Fatty Liver Disease: Revisited After a DecadeHepatology, 2020
- Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride BiosynthesisHepatology, 2018
- Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver diseaseCellular and Molecular Life Sciences, 2018
- Sex‐specific Alterations in Serology and the Expression of Liver FATP4 Protein in Offspring Exposed to High‐Fat Diet during Pregnancy and/or LactationLipids, 2018
- Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in miceHepatology, 2011
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- The plasma lipidomic signature of nonalcoholic steatohepatitis†‡Hepatology, 2009
- A lipidomic analysis of nonalcoholic fatty liver diseaseHepatology, 2007